ACQUIRED · 2024
Who Acquired Infusion Associates?
Vivo Infusion · $215.0M· 14.3× EBITDA
The acquisition
Infusion Associates was acquired by Vivo Infusion in 2024 for $215.0M. The deal was priced at 14.3× EBITDA.
Infusion Associates at time of acquisition
EBITDA
$15.0M
Deal value
$215.0M
EV / EBITDA
14.3×
Similar pharmacy acquisitions
- University Compounding Pharmacy · acquired by Fagron in 2026 · $41.5M
- Choice Specialty Pharmacy Group · acquired by Better Choice Company, Inc. in 2025 · $28.0M
- Horizon Infusions · acquired by Rubicon in 2025 · $130.0M
- KabaFusion · acquired by Nautic Partners in 2025 · $2.20B
- Soleo Health · acquired by Court Square Capital and WindRose Health in 2025 · $1.10B
Run a valuation for a similar pharmacy business
Three fields, instant range, backed by 25,592 real M&A transactions including this one.
Open the pharmacy calculator →More on pharmacy valuations
- Value a medical practice
- Value a dental practice
- Value a veterinary practice
- Pharmacy valuation calculator· head-term variant
- Pharmacy median multiples· real-deal benchmarks
- How to value a pharmacy· long-form guide
Sourced from Press reporting. Full deal page.
Citation: ExitValue.ai. (2024). Infusion Associates acquired by Vivo Infusion. https://exitvalue.ai/acquired/infusion-associates